News West Pharmaceutical Services, Inc.

Stocks

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 16:00:02 2026-11-11 EST			5-day change	1st Jan Change
412.86 ^USD	+0.08%		+1.00%	+50.05%

11-02	Jefferies Adjusts West Pharmaceutical Services Price Target to $475 From $410	MT
10-30	Stephens Adjusts West Pharmaceutical Services Price Target to $490 From $450	MT

All News

Mentions Relevance

4.YDDOyU9dJz-NEkyx0gBG5Gf4EXHSM1yA5ZIN-Go9eQs.MV2dmwsQflHYeD_ZsEsyr1aCfAKQfSbakaQgrRlTGls2dYKROxoeCfpTHQ

11-04	West to Participate in Upcoming Investor Conference	PR
11-02	Jefferies Adjusts West Pharmaceutical Services Price Target to $475 From $410	MT
10-30	Stephens Adjusts West Pharmaceutical Services Price Target to $490 From $450	MT
10-30	Deutsche Bank Adjusts West Pharmaceutical Services PT to $450 From $420, Maintains Buy Rating	MT
10-30	BNP Paribas Adjusts Price Target on West Pharmaceutical Services to $466 From $459	MT
10-30	Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $480 From $410	MT
10-29	West Pharmaceutical Services, Inc., Q3 2026 Earnings Call, Oct 29, 2026
10-29	West Pharmaceutical Services, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
10-29	West Pharmaceutical's Q3 Adjusted Earnings, Sales Rise; 2026 Outlook Increased	MT
10-29	West Pharmaceutical Services, Inc. Raises Earnings Guidance for the Full-Year 2026	CI
10-29	(WST) West Pharmaceutical Services Expects 2026 Adjusted EPS Range $9.38 to $9.48, vs. FactSet Est of $8.98	MT
10-29	(WST) West Pharmaceutical Expects 2026 Sales Range $3.41B to $3.42B vs. FactSet Est of $3.38B	MT
10-29	Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q3 Revenue $874.5M, vs. FactSet Est of $827.1M	MT
10-29	Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q3 Adjusted EPS $2.66 per Share, vs. FactSet Est of $2.20	MT
10-29	West Reports Third-Quarter 2026 Results	PR
10-28	Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 17, 2026.	CI
10-28	Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $425 From $440	MT
10-26	West Pharmaceutical Services, Inc. Enters into New Credit Agreement Providing $750 Million Revolving Credit Facility and $200 Million Term Loan Credit Facility	CI
10-20	West Pharmaceutical Services, Inc. Declares Dividend for the Fourth-Quarter Dividend, Payable on November 18, 2026	CI
10-20	West Pharmaceutical Services Raises Quarterly Dividend 18% to $0.26 a Share, Payable Nov. 18 to Holders as of Nov. 11.	MT
10-19	West Declares Quarterly Dividend	PR
10-13	TD Cowen Adjusts Price Target on West Pharmaceutical Services to $420 From $410	MT
10-08	West to Host Third-Quarter 2026 Conference Call	PR
10-07	Evercore ISI Adjusts West Pharmaceutical Services Price Target to $440 From $410	MT
10-06	Barclays Raises West Pharmaceutical Services Price Target to $440 From $400, Maintains Overweight Rating	MT